Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 246

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy

Open access
Cope, Thomas E, Rittman, Timothy, Borchert, Robin J, Jones, P Simon, Vatansever, Deniz, Allinson, Kieren, Passamonti, Luca, Vazquez Rodriguez, Patricia, Bevan-Jones, W Richard, O'Brien, John T, Rowe, James B·2018·Brain

Abstract

Alzheimer's disease and progressive supranuclear palsy (PSP) represent neurodegenerative tauopathies with predominantly cortical versus subcortical disease burden. In Alzheimer's disease, neuropathology and atrophy preferentially affect 'hub' brain regions that are densely connected. It was unclear whether hubs are differentially affected by neurodegeneration because they are more likely to receive pathological proteins that propagate trans-neuronally, in a prion-like manner, or whether they are selectively vulnerable due to a lack of local trophic factors, higher metabolic demands, or differential gene expression. We assessed the relationship between tau burden and brain functional connectivity, by combining in vivo PET imaging using the ligand AV-1451, and graph theoretic measures of resting state functional MRI in 17 patients with Alzheimer's disease, 17 patients with PSP, and 12 controls. Strongly connected nodes displayed more tau pathology in Alzheimer's disease, independently of intrinsic connectivity network, validating the predictions of theories of trans-neuronal spread but not supporting a role for metabolic demands or deficient trophic support in tau accumulation. This was not a compensatory phenomenon, as the functional consequence of increasing tau burden in Alzheimer's disease was a progressive weakening of the connectivity of these same nodes, reducing weighted degree and local efficiency and resulting in weaker 'small-world' properties. Conversely, in PSP, unlike in Alzheimer's disease, those nodes that accrued pathological tau were those that displayed graph metric properties associated with increased metabolic demand and a lack of trophic support rather than strong functional connectivity. Together, these findings go some way towards explaining why Alzheimer's disease affects large scale connectivity networks throughout cortex while neuropathology in PSP is concentrated in a small number of subcortical structures. Further, we demonstrate that in PSP increasing tau burden in midbrain and deep nuclei was associated with strengthened cortico-cortical functional connectivity. Disrupted cortico-subcortical and cortico-brainstem interactions meant that information transfer took less direct paths, passing through a larger number of cortical nodes, reducing closeness centrality and eigenvector centrality in PSP, while increasing weighted degree, clustering, betweenness centrality and local efficiency. Our results have wide-ranging implications, from the validation of models of tau trafficking in humans to understanding the relationship between regional tau burden and brain functional reorganization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awx347

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 57

  1. Abdelnour, 2014, Network diffusion accurately models the relationship between structural and functional brain connectivity networks, Neuroimage, 90, 335, 10.1016/j.neuroimage.2013.12.039 · DOI · Paper page
  2. Ahmed, 2014, A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity, Acta Neuropathol, 127, 667, 10.1007/s00401-014-1254-6 · DOI · Paper page
  3. Albert, 1974, The ‘subcortical dementia’ of progressive supranuclear palsy, J Neurol Neurosurg Psychiatry, 37, 121, 10.1136/jnnp.37.2.121 · DOI · Paper page
  4. Appel, 1981, A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease, Ann Neurol, 10, 499, 10.1002/ana.410100602 · DOI · Paper page
  5. Baker, 1994, Induction of β (A4)-amyloid in primates by injection of Alzheimer’s disease brain homogenate, Mol Neurobiol, 8, 25, 10.1007/BF02778005 · DOI
  6. Bevan-Jones, 2017, [18F], J Neurol Neurosurg Psychiatry
  7. Bevan-Jones, 2017, Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses, BMJ Open, 7, e013187, 10.1136/bmjopen-2016-013187 · DOI
  8. Braak, 1995, Staging of Alzheimer's disease-related neurofibrillary changes, Neurobiol Aging, 16, 271, 10.1016/0197-4580(95)00021-6 · DOI · Paper page
  9. Braak, 2013, Amyotrophic lateral sclerosis—a model of corticofugal axonal spread, Nat Rev Neurol, 9, 708, 10.1038/nrneurol.2013.221 · DOI · Paper page
  10. Chennu, 2017, Brain networks predict metabolism, diagnosis and prognosis at the bedside in disorders of consciousness, Brain, 140, 2120, 10.1093/brain/awx163 · DOI · Paper page
  11. Clavaguera, 2013, Brain homogenates from human tauopathies induce tau inclusions in mouse brain, Proc Natl Acad Sci USA, 110, 9535, 10.1073/pnas.1301175110 · DOI · Paper page
  12. Cordato, 2005, Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy, Brain, 128, 1259, 10.1093/brain/awh508 · DOI
  13. Cordato, 2002, Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy, Brain, 125, 789, 10.1093/brain/awf082 · DOI
  14. D'Antona, 1985, Subcortical dementia, Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain, 108 (Pt 3), 785
  15. Dai, 2014, Identifying and mapping connectivity patterns of brain network hubs in Alzheimer's disease, Cereb Cortex
  16. de Haan, 2012, Activity dependent degeneration explains hub vulnerability in Alzheimer's disease, PLoS Comput Biol, 8, e1002582, 10.1371/journal.pcbi.1002582 · DOI · Paper page
  17. Durrett, 2010, Some features of the spread of epidemics and information on a random graph, Proc Natl Acad Sci USA, 107, 4491, 10.1073/pnas.0914402107 · DOI
  18. Ellison, 2012, Neuropathology: a reference text of CNS pathology
  19. Falcon, 2015, Conformation determines the seeding potencies of native and recombinant Tau aggregates, J Biol Chem, 290, 1049, 10.1074/jbc.M114.589309 · DOI · Paper page
  20. Foster, 1988, Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography, Ann Neurol, 24, 399, 10.1002/ana.410240308 · DOI · Paper page
  21. Gardner, 2013, Intrinsic connectivity network disruption in progressive supranuclear palsy, Ann Neurol, 73, 603, 10.1002/ana.23844 · DOI
  22. Goedert, 2015, Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled Aβ, tau, and α-synuclein, Science, 349, 1255555, 10.1126/science.1255555 · DOI · Paper page
  23. Goedert, 2006, A century of Alzheimer's disease, Science, 314, 777, 10.1126/science.1132814 · DOI · Paper page
  24. Golbe, 2007, A clinical rating scale for progressive supranuclear palsy, Brain, 130, 1552, 10.1093/brain/awm032 · DOI · Paper page
  25. Granovetter, 1983, The strength of weak ties: a network theory revisited, Soc Theory, 201, 10.2307/202051 · DOI · Paper page
  26. Guo, 2014, Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases, Nat Med, 20, 130, 10.1038/nm.3457 · DOI · Paper page
  27. Höglinger, 2017, Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society Criteria, Mov Disord, 32, 853, 10.1002/mds.26987 · DOI · Paper page
  28. Ittner, 2011, Amyloid-[beta] and tau–a toxic pas de deux in Alzheimer's disease, Nat Rev Neurosci, 12, 65, 10.1038/nrn2967 · DOI · Paper page
  29. Jones, 2015, Cascading network failure across the Alzheimer’s disease spectrum, Brain, 139, 547, 10.1093/brain/awv338 · DOI · Paper page
  30. Joyce, 2010, A new measure of centrality for brain networks, PLoS One, 5, e12200, 10.1371/journal.pone.0012200 · DOI · Paper page
  31. Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann Neurol, 55, 306, 10.1002/ana.20009 · DOI · Paper page
  32. Kundu, 2012, Differentiating BOLD and non-BOLD signals in fMRI time series using multi-echo EPI, Neuroimage, 60, 1759, 10.1016/j.neuroimage.2011.12.028 · DOI · Paper page
  33. Lehmann, 2013, Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease, Brain, 136, 844, 10.1093/brain/aws327 · DOI · Paper page
  34. Liu, 2012, Trans-synaptic spread of tau pathology in vivo, PLoS One, 7, e31302, 10.1371/journal.pone.0031302 · DOI · Paper page
  35. Liu, 2001, Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy, Ann Neurol, 50, 494, 10.1002/ana.1159 · DOI
  36. Maestú, 2015, A multicenter study of the early detection of synaptic dysfunction in mild cognitive impairment using magnetoencephalography-derived functional connectivity, Neuroimage Clin, 9, 103, 10.1016/j.nicl.2015.07.011 · DOI
  37. Mandelli, 2016, Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia, Brain, 139 (Pt 10), 2778, 10.1093/brain/aww195 · DOI · Paper page
  38. Nonaka, 2010, Seeded aggregation and toxicity of α-synuclein and tau: cellular models of neurodegenerative diseases, J Biol Chem, 285, 34885, 10.1074/jbc.M110.148460 · DOI · Paper page
  39. Okello, 2009, Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study, Neurology, 73, 754, 10.1212/WNL.0b013e3181b23564 · DOI · Paper page
  40. Ossenkoppele, 2015, Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy, Ann Neurol, 77, 338, 10.1002/ana.24321 · DOI
  41. Ossenkoppele, 2016, Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease, Brain, 139 (Pt 5), 1551, 10.1093/brain/aww027 · DOI · Paper page
  42. Passamonti, 2017, 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy, Brain, 140, 781
  43. Power, 2012, Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion, Neuroimage, 59, 2142, 10.1016/j.neuroimage.2011.10.018 · DOI · Paper page
  44. R Core Team, 2016, R: a language and environment for statistical computing
  45. Raj, 2012, A network diffusion model of disease progression in dementia, Neuron, 73, 1204, 10.1016/j.neuron.2011.12.040 · DOI · Paper page
  46. Raj, 2015, Network diffusion model of progression predicts longitudinal patterns of atrophy and metabolism in Alzheimer’s disease, Cell Rep, 10, 359, 10.1016/j.celrep.2014.12.034 · DOI · Paper page
  47. Rittman, 2016, Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy, Neurobiol Aging, 48, 153, 10.1016/j.neurobiolaging.2016.09.001 · DOI
  48. Saxena, 2011, Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration, Neuron, 71, 35, 10.1016/j.neuron.2011.06.031 · DOI · Paper page
  49. Schofield, 2012, The relationship between clinical and pathological variables in Richardson’s syndrome, J Neurol, 259, 482, 10.1007/s00415-011-6205-8 · DOI
  50. Sisodia, 1990, Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing, Science, 248, 492, 10.1126/science.1691865 · DOI · Paper page
  51. Stam, 2006, Small-world networks and functional connectivity in Alzheimer's disease, Cereb Cortex, 17, 92, 10.1093/cercor/bhj127 · DOI · Paper page
  52. Stam, 2014, Modern network science of neurological disorders, Nat Rev Neurosci, 15, 683, 10.1038/nrn3801 · DOI · Paper page
  53. The Mathworks Inc, 2015, Matlab and statistics and machine learning toolbox. Release 2015b ed
  54. Williams, 2007, Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome, Brain, 130, 1566, 10.1093/brain/awm104 · DOI · Paper page
  55. Xia, 2017, Multimodal PET imaging of amyloid and Tau pathology in Alzheimer disease and non–Alzheimer disease dementias, PET Clin, 12, 351, 10.1016/j.cpet.2017.02.005 · DOI
  56. Ypma, 2016, Statistical analysis of tract-tracing experiments demonstrates a dense, complex cortical network in the mouse, PLoS Comput Biol, 12, e1005104, 10.1371/journal.pcbi.1005104 · DOI
  57. Zhou, 2012, Predicting regional neurodegeneration from the healthy brain functional connectome, Neuron, 73, 1216, 10.1016/j.neuron.2012.03.004 · DOI · Paper page

Cited by

See all 246

Metadata

Authors
Cope, T. E., Rittman, T., Borchert, R. J., Jones, P. S., Vatansever, D., Allinson, K., Passamonti, L., Vazquez Rodriguez, P., Bevan-Jones, W. R., O'Brien, J. T., & Rowe, J. B.
Venue
Brain
Published
2018-01-05
Volume
141
Issue
2
Pages
550-567
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2766289228
Cited by
246
References
35
FWCI
12.60
Type
journal article
Language
en
Open access
hybrid
Funders
  • National Institutes of Health
  • Wellcome Trust (JBR 103838)
  • National Institute for Health Research (RG64473)
  • PSP Association
  • Medical Research Council (MC-A060-5PQ30)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy. https://app.cochat.ai/papers/10.1093/brain/awx347
The paper
Cope, T. E., Rittman, T., Borchert, R. J., Jones, P. S., Vatansever, D., Allinson, K., Passamonti, L., Vazquez Rodriguez, P., Bevan-Jones, W. R., O'Brien, J. T., & Rowe, J. B. (2018). Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy. Brain. https://doi.org/10.1093/brain/awx347

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.